NCI | Technology Transfer

Recombinant Immunotoxin Targeting Mesothelin

Read more about Recombinant Immunotoxin Targeting Mesothelin

Australia
2012253896
Filed on 2012-05-04

Engineered Antibody Constant Domain Molecules

Read more about Engineered Antibody Constant Domain Molecules

US Patent 9,527,903
Filed on 2013-10-01

MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)

Read more about MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)

Spain
07867402.5
Filed on 2009-04-24

MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)

Read more about MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)

Germany
07867402.5
Filed on 2009-04-24

Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid

Read more about Lentivirus Expressing Mutant Forms On Human Thymidylate Monophosphate Kinase 9tmpk), F105Y Adn R16G Lid

US Application 12/843,238
Filed on 2010-07-26

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER

Read more about ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER

US Patent 9,266,960
Filed on 2013-10-24

Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use

Read more about Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use

US Patent 9,441,048
Filed on 2013-05-21

ANTIBODIES FOR TUMOR GANGLIOSIDES

Read more about ANTIBODIES FOR TUMOR GANGLIOSIDES

Patent Cooperation Treaty
PCT/US2011/060759
Filed on 2011-11-15

AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY

Read more about AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY

US Application 14/031,699
Filed on 2013-09-19

Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer

Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer

Japan
2014-503673
Filed on 2013-10-03

Subscribe to NCI